|
|
|
The 3rd World Congress on
Controversies in Ophthalmology (COPHy)
Anterior Segment, Retina, Glaucoma
Istanbul, Turkey, March 22 - 25, 2012 |
|
 |
| Glaucoma Section |
 |
|
|
|
Controversies in Medical Treatment of Glaucoma
Room: Genéve-Luzem
08:30-10:00
Chairpersons: A. Heijl, Sweden & K. Martin, UK
|
|
08:30-09:00
08:30-08:40
08:40-08:50
08:50-09:00
09:00-09:30
09:00-09:10
09:10-09:20
09:20-09:30 |
Debate I: Initial monotherapy is an obsolete dogma
Yes
A. Heijl, Sweden
No
S. Gandolfi, Italy
Discussion
Debate II: Are any currently available drugs neuroprotective?
Yes
S. Gandolfi, Italy
No
K. Martin, UK
Discussion
|
|
09:30-10:00 |
Debate III: Exfoliation and ocular hypertension is such a dangerous combination that all patients should be treated |
|
09:30-09:40
09:40-09:50
09:50-10:00 |
Yes
A. Heijl, Sweden
No
S. Vernon, UK (abstract from E. Hoffman,Germany) 
Discussion
|
|
Controversies in Glaucoma Diagnosis and Progression
Room: Genéve-Luzem
10:30-12:00
Chairpersons: A. Heijl, Sweden & K. Martin, UK
|
|
10:30-11:00
10:30-10:40
10:40-10:50
10:50-11:00
11:00-11:30 |
Debate I: Molecular biomarkers will be useful
Yes
F. Grus, Germany
No
K. Martin, UK
Discussion
Debate II: It is time to stop confusing ophthalmologists with talk of so-called "selective perimetry" |
|
11:00-11:10
11:10-11:20
11:20-11:30
11:30-12:00
11:30-11:40
11:40-11:50
11:50-12:00 |
Yes
A. Heijl, Sweden
No
A. Viswanathan, UK
Discussion
Debate III: How best to assess progression in the future?
Smarter use of existing methodologies
A. Viswanathan, UK
Imaging sick and dying cells
K. Martin, UK
Discussion
|
|
Controversies in Laser Treatment in Glaucoma
Room: Genéve-Luzem
14:00-15:30
Chairperson: A. Heijl, Sweden
|
|
14:00-14:30
14:00-14:10
14:10-14:20
14:20-14:30
14:30-15:00
14:30-14:40
14:40-14:50
14:50-15:00
15:00-15:30
15:00-15:10
15:10-15:20
15:20-15:30
|
Debate I: SLT should be first-line?
Yes
S. Gandolfi, Italy
No
G. Gazzard, UK
Discussion
Debate II: Should endodiode be used more?
Yes
P. Bloom, UK
No
S. Vernon, UK
Discussion
Debate III: Should iridoplasty be used more?
Yes
A. White, UK
No
G. Gazzard, UK
|
|
Controversies in Surgical Management of Glaucoma
Room: Fuji 2
08:30-10:00
Chairperson: A. Heijl, Sweden
|
|
08:30-09:00
08:30-08:40
08:40-08:50
08:50-09:00
09:00-10:00
09:00-09:15
09:15-09:30
09:30-09:45
09:45-10:00
|
Debate I: What is the best treatment for neovascular glaucoma?
Tubes
J. Brookes, UK
Cycloablation
S. Vernon, UK
Discussion
Debate II: What is the most promising new surgical technique?
iStent
P. Bloom, UK
Trabectome
A. White, UK
Canaloplasty
M. Tetz, Germany
Better use of conventional tubes
J. Brookes, UK
|
|
|
|
|
WebStudio.co.il